Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: A meta-analysis of long-term omeprazole trials

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 3, 1997, Pages 473-482

  Carlsson, R ^a,b   Galmiche, J P ^c   Dent, J ^d   Lundell, L ^a   Frison, L ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITÉ DE NANTES   (France)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ENDOSCOPY; ESOPHAGITIS; FEMALE; HEARTBURN; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; REMISSION; SMOKING;

EID: 0030799612     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00167.x     Document Type: Article

References (45)

1. Richter JE. Dyspepsia: Organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991; 26(Suppl. 182): 11-6.
2. Brunnen PL, Karmody AM, Needham CD. Severe peptic oesophagitis. Gut 1969; 10: 831-7.
3. Lööf L, Götell P, Elfberg B. The incidence of reflux esophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 1993; 28: 113-8.
4. Sonnenberg A. Epidemiologie und Spontanverlauf der Reluxkrankheit. In: Blum AL, Siewert JR, eds. Refluxtherapie. Berlin: Springer Verlag, 1981: 85-106.
5. Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989; 24(Suppl. 156): 7-13.
6. Spechler S. Epidemiology and natural history of gastroesophageal reflux disease. Digestion 1992: 51(Suppl. 1): 24-9.
7. Dent J. Roles of gastric acid and pH in the pathogenesis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1994; 29(Suppl. 201): 55-61.
8. Masclee AAM, de Best ACAM, de Graaf R, Cluysenaer OJJ, Jansen JBMJ. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy. Scand J Gastroenterol 1990; 25: 225-30.
9. Galmiche J-P, Janssens J. The pathophysiology of gastro-oesophageal reflux disease: An overview. Scand J Gastroenterol 1995; 30(Suppl. 211): 7-18.
10. 2-antagonists in uncomplicated esophagitis. Scand J Gastroenterol 1989; 24: 671-7.
11. Orlando RC. Pathophysiology of gastroesophageal reflux disease: Esophageal epithelial resistance. In: Castell DO, ed. The Esophagus. Boston, Toronto, London: Little, Brown and Company, 1992: 463-78.
12. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: A review of animal and human studies. Gastroenterology 1995; 108: 1987-1907.
13. Klinkenberg-Knol EC, Jansen JMBJ, Festen HPM, Meuwissen SGM, Lamers CBHW. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; i: 349-51.
14. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology, 1988; 95: 903-12.
15. Havelund T, Laursen LS, Skoubo-Kristensen E, et al. Omeprazole and ranitidine in the treatment of reflux oesophagitis. Br Med J 1988; 296: 89-92.
16. Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts JL. Omeprazoie (40 mg) is superior to ranitidine in the short term treatment of ulcerated reflux esophagitis. Dig Dis Sci 1988; 3: 523-9.
17. Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results from a double-blind, randomized, multicentre study. Scand J Gastroenterol 1988; 23: 625-32.
18. Zeitoun P, Rampai P, Barbier P, Isal J-P, Eriksson S, Carlsson R. Omeprazole (20 mg o.m.) vs. ranitidine (150 mg b.i.d.) in reflux esophagitis. Results of a double-blind, randomized trial. Gastroenterol Clin Biol 1989; 13: 457-62.
19. Bate CM, Keeling PWN, O'Morain CO, et al. Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations, Cut 1990; 31: 968-72.
20. Bate CM, Crowe JF, Dickinson RJ. et al. Reflux oesophagitis resolves more rapidly with omeprazole 20 mg once daily than with ranitidine 150 mg twice daily: Omeprazole 40 mg once daily provides further benefit in unresponsive patients. Br J Clin Res 1991; 2: 133-48.
21. Sontag SJ, Hirschowitz BI, Holt S, et al. Two doses of omeprazole vs. placebo in symptomatic erosive esophagitis: The U.S. multicenter study. Gastroenterology 1992; 102: 109-18.
22. Hallebakk JG, Berstad A, Carling L, et al. Lansoprazole vs. omeprazole in short-term treatment of reflux oesophagitis: Results of a Scandinavian multicentre trial. Scand J Gastroenterol 1993; 28: 224-8.
23. +-ATPase inhibitor: A controlled, double-blind study. Am J Gastroenterol 1993; 88: 1212-7.
24. Bader JP, Delchier JC. Clinical efficacy of pantoprazole compared with ranitidine. Aliment Pharm Ther 1994; 8(Suppl. 1): 47-52.
25. Zeitoun P, Barbier P, Cayphas J-P, Isal J-P, Carlsson R. comparison of two dosage regimens of omeprazole - 10 mg once daily and 20 mg weekends - as prophylaxis against recurrence of reflux esophagitis. Hepatogastroenterol 1989; 36: 279-80(Abstract).
26. Staerk Laursen L, Havelund T, Bondesen S, et al. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study. Scand J Gastroenterol 1995; 30: 839-46.
27. Sontag S, Robinson M, Roufail W, et al. Daily omeprazole (OME) is needed to maintain healing in erosive esophagitis (EE): A U.S., multicenter double-blind study. Am J Gastroenterol 1992; 87: A1258(Abstract).
28. Dent J, Yeomans N, Mackinnon M, et al. Omeprazole vs. ranitidine for prevention of relapse in reflux oesophagitis. A controlled double-blind trial of their efficacy and safety. Gut 1994; 35: 590-8.
29. Hallerbäck B, Unge P, Carling L, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994; 107: 1305-11.
30. Cox DR. Regression models and life tables. J Royal Stat Soc 1972; B34: 187-220.
31. Pocock S. Clinical trials. Chichester, England: Wiley, 1983: 221-7.
32. Bell NJ, Hunt RH. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 1992; 33: 118-24.
33. Bate CM, Booth SN, Crowe JP, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995; 36: 492-8.
34. Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux. Scand J Gastroenterol 1987; 22: 714-8.
35. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8.
36. Green JRB. Is there such an entity as mild oesophagitis? Eur J Clin Res 1993; 4: 29-34.
37. Landahl S, Andersson T, Larsson M, et al. Pharmacokinetic study of omeprazole in elderly healthy volunteers. Clin Pharmacokinet 1992; 23: 469-76.
38. Dennish GVV, Castell DO. Inhibitory effect of smoking on the lower esophageal sphincter. N Engl J Med 1971; 284: 1136.
39. Stanciu C, Bennett JR. Smoking and gastro-oesophageal reflux. Br Med J 1972; 3: 793.
40. Koelz HR, Birchler R, Bretholtz A, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198-205.
41. Kuster E, Ros E, Toledo-Pimentel V, et al. Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients. Gut 1994; 35: 8-14.
42. Joelsson B, Johnsson F. Heartburn the acid test. Gut 1989; 30: 1523-5.
43. Ruth M, Enbom H, Lundell L, Lönroth H, Sandberg N, Sandmark S. The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis. Scand J Gastroenterol 1988; 23: 1141-6.
44. Fiorucci S, Santucci L, Morelli A. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis. Am J Gastroenterol 1990; 85: 1458-62.
45. Schindlbeck NE, Klauser AG, Voderholzer WA, Müller-Lissner SA. Mean acidity or percentage reflux time in oesophageal pH-monitoring. Eur J Gastroenterol Hepatol 1993; 5: 155-9.